Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 216 entries
Sorted by: Best Match Show Resources per page
Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases.

Journal of the American Chemical Society

Sensi M, Baffert C, Greco C, Caserta G, Gauquelin C, Saujet L, Fontecave M, Roy S, Artero V, Soucaille P, Meynial-Salles I, Bottin H, de Gioia L, Fourmond V, Léger C, Bertini L.
PMID: 27649394
J Am Chem Soc. 2016 Oct 19;138(41):13612-13618. doi: 10.1021/jacs.6b06603. Epub 2016 Oct 06.

FeFe hydrogenases catalyze H

Cite
Sensi M, Baffert C, Greco C, et al. Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. J Am Chem Soc. 2016;138(41):13612-13618doi: 10.1021/jacs.6b06603.
Sensi, M., Baffert, C., Greco, C., Caserta, G., Gauquelin, C., Saujet, L., Fontecave, M., Roy, S., Artero, V., Soucaille, P., Meynial-Salles, I., Bottin, H., de Gioia, L., Fourmond, V., Léger, C., & Bertini, L. (2016). Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. Journal of the American Chemical Society, 138(41), 13612-13618. https://doi.org/10.1021/jacs.6b06603
Sensi, Matteo, et al. "Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases." Journal of the American Chemical Society vol. 138,41 (2016): 13612-13618. doi: https://doi.org/10.1021/jacs.6b06603
Sensi M, Baffert C, Greco C, Caserta G, Gauquelin C, Saujet L, Fontecave M, Roy S, Artero V, Soucaille P, Meynial-Salles I, Bottin H, de Gioia L, Fourmond V, Léger C, Bertini L. Reactivity of the Excited States of the H-Cluster of FeFe Hydrogenases. J Am Chem Soc. 2016 Oct 19;138(41):13612-13618. doi: 10.1021/jacs.6b06603. Epub 2016 Oct 06. PMID: 27649394.
Copy Download .nbib Format: NLM
MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.

Frontiers in immunology

Monaci E, Mancini F, Lofano G, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Giraldi M, Galletti B, Rossi Paccani S, Torre A, Fontana MR, Grandi G, de Gregorio E, Bensi G, Chiarot E, Nuti S, Bagnoli F, Soldaini E, Bertholet S.
PMID: 26441955
Front Immunol. 2015 Sep 07;6:439. doi: 10.3389/fimmu.2015.00439. eCollection 2015.

Staphylococcus aureus (S. aureus) is an important opportunistic pathogen that may cause invasive life-threatening infections, like sepsis and pneumonia. Due to the increasing antibiotic resistance, the development of an effective vaccine against S. aureus is needed. Although a correlate...

Cite
Monaci E, Mancini F, Lofano G, et al. MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Front Immunol. 2015;6:439doi: 10.3389/fimmu.2015.00439.
Monaci, E., Mancini, F., Lofano, G., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Giraldi, M., Galletti, B., Rossi Paccani, S., Torre, A., Fontana, M. R., Grandi, G., de Gregorio, E., Bensi, G., Chiarot, E., Nuti, S., Bagnoli, F., Soldaini, E., & Bertholet, S. (2015). MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Frontiers in immunology, 6439. https://doi.org/10.3389/fimmu.2015.00439
Monaci, Elisabetta, et al. "MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers." Frontiers in immunology vol. 6 (2015): 439. doi: https://doi.org/10.3389/fimmu.2015.00439
Monaci E, Mancini F, Lofano G, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Giraldi M, Galletti B, Rossi Paccani S, Torre A, Fontana MR, Grandi G, de Gregorio E, Bensi G, Chiarot E, Nuti S, Bagnoli F, Soldaini E, Bertholet S. MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers. Front Immunol. 2015 Sep 07;6:439. doi: 10.3389/fimmu.2015.00439. eCollection 2015. PMID: 26441955; PMCID: PMC4561515.
Copy Download .nbib Format: NLM
Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

World journal of virology

Asensi V, Collazos J, Valle-Garay E.
PMID: 26279978
World J Virol. 2015 Aug 12;4(3):169-77. doi: 10.5501/wjv.v4.i3.169.

Pharmacogenetics refers to the effect of single nucleotide polymorphisms (SNPs) within human genes on drug therapy outcome. Its study might help clinicians to increase the efficacy of antiretroviral drugs by improving their pharmacokinetics and pharmacodynamics and by decreasing their...

Cite
Asensi V, Collazos J, Valle-Garay E. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World J Virol. 2015;4(3):169-77doi: 10.5501/wjv.v4.i3.169.
Asensi, V., Collazos, J., & Valle-Garay, E. (2015). Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World journal of virology, 4(3), 169-77. https://doi.org/10.5501/wjv.v4.i3.169
Asensi, Victor, et al. "Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics." World journal of virology vol. 4,3 (2015): 169-77. doi: https://doi.org/10.5501/wjv.v4.i3.169
Asensi V, Collazos J, Valle-Garay E. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World J Virol. 2015 Aug 12;4(3):169-77. doi: 10.5501/wjv.v4.i3.169. PMID: 26279978; PMCID: PMC4534808.
Copy Download .nbib Format: NLM
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X).

Case reports in pediatrics

Cappella M, Graziani V, Pragliola A, Sensi A, Hussain K, Muratori C, Marchetti F.
PMID: 26064751
Case Rep Pediatr. 2015;2015:561974. doi: 10.1155/2015/561974. Epub 2015 Apr 29.

Hyperinsulinemic hypoglycaemia (HH) is a group of clinically, genetically, and morphologically heterogeneous disorders characterized by dysregulation of insulin secretion by pancreatic beta cells. HH can either be congenital genetic hyperinsulinism or associated with metabolic disorder and syndromic condition. Early...

Cite
Cappella M, Graziani V, Pragliola A, et al. Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case Rep Pediatr. 2015;2015:561974doi: 10.1155/2015/561974.
Cappella, M., Graziani, V., Pragliola, A., Sensi, A., Hussain, K., Muratori, C., & Marchetti, F. (2015). Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case reports in pediatrics, 2015561974. https://doi.org/10.1155/2015/561974
Cappella, Michela, et al. "Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X)." Case reports in pediatrics vol. 2015 (2015): 561974. doi: https://doi.org/10.1155/2015/561974
Cappella M, Graziani V, Pragliola A, Sensi A, Hussain K, Muratori C, Marchetti F. Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case Rep Pediatr. 2015;2015:561974. doi: 10.1155/2015/561974. Epub 2015 Apr 29. PMID: 26064751; PMCID: PMC4429216.
Copy Download .nbib Format: NLM
Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma.

International journal of immunopathology and pharmacology

Riccioni G, Castronuovo M, De Benedictis M, Pace - Palitti V, Di Gioacchino M, Della Vecchia R, Schiavone C, Sensi S, Guagnano MT.
PMID: 12604023
Int J Immunopathol Pharmacol. 2001 May-Aug;14(2):87-92.

Asthma is one of the most common chronic diseases in children and adults. Recent studies have shown that in asthmatic patients treated with inhaled corticosteroids there is a better disease’s control when adding a second drug, than increasing the...

Cite
Riccioni G, Castronuovo M, De Benedictis M, et al. Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2001;14(2):87-92
Riccioni, G., Castronuovo, M., De Benedictis, M., Pace - Palitti, V., Di Gioacchino, M., Della Vecchia, R., Schiavone, C., Sensi, S., & Guagnano, M. T. (2001). Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. International journal of immunopathology and pharmacology, 14(2), 87-92.
Riccioni, G, et al. "Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma." International journal of immunopathology and pharmacology vol. 14,2 (2001): 87-92.
Riccioni G, Castronuovo M, De Benedictis M, Pace - Palitti V, Di Gioacchino M, Della Vecchia R, Schiavone C, Sensi S, Guagnano MT. Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2001 May-Aug;14(2):87-92. PMID: 12604023.
Copy Download .nbib Format: NLM
Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma.

International journal of immunopathology and pharmacology

Riccioni G, Ballone E, D'Orazio N, Sensi S, Di Nicola M, Di Mascio R, Santilli F, Guagnano MT, Della Vecchia R.
PMID: 12590877
Int J Immunopathol Pharmacol. 2002 May-Aug;15(2):149-155. doi: 10.1177/039463200201500210.

Insufficient data exist to evaluate the comparative effects of inhaled corticosteroids (ICS) versus leukotriene receptor antagonist (LTRA) on airway inflammation and quality of life (QoL). The aim of the study was to compare the effectiveness of montelukast compared to...

Cite
Riccioni G, Ballone E, D'Orazio N, et al. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2002;15(2):149-155doi: 10.1177/039463200201500210.
Riccioni, G., Ballone, E., D'Orazio, N., Sensi, S., Di Nicola, M., Di Mascio, R., Santilli, F., Guagnano, M. T., & Della Vecchia, R. (2002). Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. International journal of immunopathology and pharmacology, 15(2), 149-155. https://doi.org/10.1177/039463200201500210
Riccioni, G., et al. "Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma." International journal of immunopathology and pharmacology vol. 15,2 (2002): 149-155. doi: https://doi.org/10.1177/039463200201500210
Riccioni G, Ballone E, D'Orazio N, Sensi S, Di Nicola M, Di Mascio R, Santilli F, Guagnano MT, Della Vecchia R. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. Int J Immunopathol Pharmacol. 2002 May-Aug;15(2):149-155. doi: 10.1177/039463200201500210. PMID: 12590877.
Copy Download .nbib Format: NLM
Nontoxigenic Strains of Pseudomonas syringae pv. phaseolicola Are a Main Cause of Halo Blight of Beans in Spain and Escape Current Detection Methods.

Phytopathology

Rico A, López R, Asensio C, Aizpún MT, Asensio-S-Manzanera MC, Murillo J.
PMID: 18943619
Phytopathology. 2003 Dec;93(12):1553-9. doi: 10.1094/PHYTO.2003.93.12.1553.

ABSTRACT From a collection of 152 pseudomonads isolated from diseased beans in Spain, 138 (91%) of the strains were identified as Pseudomonas syringae pv. phaseolicola and the rest as P. syringae pv. syringae. The P. syringae pv. phaseolicola strains...

Cite
Rico A, López R, Asensio C, et al. Nontoxigenic Strains of Pseudomonas syringae pv. phaseolicola Are a Main Cause of Halo Blight of Beans in Spain and Escape Current Detection Methods. Phytopathology. 2003;93(12):1553-9doi: 10.1094/PHYTO.2003.93.12.1553.
Rico, A., López, R., Asensio, C., Aizpún, M. T., Asensio-S-Manzanera, M. C., & Murillo, J. (2003). Nontoxigenic Strains of Pseudomonas syringae pv. phaseolicola Are a Main Cause of Halo Blight of Beans in Spain and Escape Current Detection Methods. Phytopathology, 93(12), 1553-9. https://doi.org/10.1094/PHYTO.2003.93.12.1553
Rico, Arantza, et al. "Nontoxigenic Strains of Pseudomonas syringae pv. phaseolicola Are a Main Cause of Halo Blight of Beans in Spain and Escape Current Detection Methods." Phytopathology vol. 93,12 (2003): 1553-9. doi: https://doi.org/10.1094/PHYTO.2003.93.12.1553
Rico A, López R, Asensio C, Aizpún MT, Asensio-S-Manzanera MC, Murillo J. Nontoxigenic Strains of Pseudomonas syringae pv. phaseolicola Are a Main Cause of Halo Blight of Beans in Spain and Escape Current Detection Methods. Phytopathology. 2003 Dec;93(12):1553-9. doi: 10.1094/PHYTO.2003.93.12.1553. PMID: 18943619.
Copy Download .nbib Format: NLM
Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study.

Chemical communications (Cambridge, England)

Park J, Barolo C, Sauvage F, Barbero N, Benzi C, Quagliotto P, Coluccia S, Di Censo D, Grätzel M, Nazeeruddin MK, Viscardi G.
PMID: 22282151
Chem Commun (Camb). 2012 Mar 14;48(22):2782-4. doi: 10.1039/c2cc17187b. Epub 2012 Jan 26.

A symmetric squaraine and its related non-symmetric structure are shown to have comparable efficiencies in DSCs, but with undoubtedly advantages in the low cost and easiness of synthesis for the symmetrical structure.

Cite
Park J, Barolo C, Sauvage F, et al. Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study. Chem Commun (Camb). 2012;48(22):2782-4doi: 10.1039/c2cc17187b.
Park, J., Barolo, C., Sauvage, F., Barbero, N., Benzi, C., Quagliotto, P., Coluccia, S., Di Censo, D., Grätzel, M., Nazeeruddin, M. K., & Viscardi, G. (2012). Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study. Chemical communications (Cambridge, England), 48(22), 2782-4. https://doi.org/10.1039/c2cc17187b
Park, Jinhyung, et al. "Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study." Chemical communications (Cambridge, England) vol. 48,22 (2012): 2782-4. doi: https://doi.org/10.1039/c2cc17187b
Park J, Barolo C, Sauvage F, Barbero N, Benzi C, Quagliotto P, Coluccia S, Di Censo D, Grätzel M, Nazeeruddin MK, Viscardi G. Symmetric vs. asymmetric squaraines as photosensitisers in mesoscopic injection solar cells: a structure-property relationship study. Chem Commun (Camb). 2012 Mar 14;48(22):2782-4. doi: 10.1039/c2cc17187b. Epub 2012 Jan 26. PMID: 22282151.
Copy Download .nbib Format: NLM
Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies.

The Neurohospitalist

Marrodan M, Bensi C, Alessandro L, Muggeri AD, Farez MF.
PMID: 30245767
Neurohospitalist. 2018 Oct;8(4):177-182. doi: 10.1177/1941874418773924. Epub 2018 May 06.

BACKGROUND AND PURPOSE: Although incidence rates vary, infectious, autoimmune, and neoplastic diseases can all cause chronic and subacute meningitis (CSM). We report a Latin-American, single center, CSM case series, analyzing the main clinical characteristics as well as ancillary diagnostic...

Cite
Marrodan M, Bensi C, Alessandro L, et al. Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. Neurohospitalist. 2018;8(4):177-182doi: 10.1177/1941874418773924.
Marrodan, M., Bensi, C., Alessandro, L., Muggeri, A. D., & Farez, M. F. (2018). Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. The Neurohospitalist, 8(4), 177-182. https://doi.org/10.1177/1941874418773924
Marrodan, Mariano, et al. "Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies." The Neurohospitalist vol. 8,4 (2018): 177-182. doi: https://doi.org/10.1177/1941874418773924
Marrodan M, Bensi C, Alessandro L, Muggeri AD, Farez MF. Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. Neurohospitalist. 2018 Oct;8(4):177-182. doi: 10.1177/1941874418773924. Epub 2018 May 06. PMID: 30245767; PMCID: PMC6146350.
Copy Download .nbib Format: NLM
Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery?.

Stroke research and treatment

Pedrini L, Magnoni F, Sensi L, Pisano E, Ballestrazzi MS, Cirelli MR, Pilato A.
PMID: 22135770
Stroke Res Treat. 2012;2012:156975. doi: 10.1155/2012/156975. Epub 2011 Nov 09.

Guidelines do not include cerebral oximetry among monitoring for carotid endarterectomy (CEA). The purpose of this study was to evaluate the reliability of near-infrared spectroscopy (NIRS) in the detection of clamping ischemia and in the prevention of clamping-related neurologic...

Cite
Pedrini L, Magnoni F, Sensi L, et al. Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery?. Stroke Res Treat. 2011;2012:156975doi: 10.1155/2012/156975.
Pedrini, L., Magnoni, F., Sensi, L., Pisano, E., Ballestrazzi, M. S., Cirelli, M. R., & Pilato, A. (2012). Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery?. Stroke research and treatment, 2012156975. https://doi.org/10.1155/2012/156975
Pedrini, Luciano, et al. "Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery?." Stroke research and treatment vol. 2012 (2012): 156975. doi: https://doi.org/10.1155/2012/156975
Pedrini L, Magnoni F, Sensi L, Pisano E, Ballestrazzi MS, Cirelli MR, Pilato A. Is Near-Infrared Spectroscopy a Reliable Method to Evaluate Clamping Ischemia during Carotid Surgery?. Stroke Res Treat. 2012;2012:156975. doi: 10.1155/2012/156975. Epub 2011 Nov 09. PMID: 22135770; PMCID: PMC3216275.
Copy Download .nbib Format: NLM
The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response.

Cancer communications (London, England)

Devecchi A, De Cecco L, Dugo M, Penso D, Dagrada G, Brich S, Stacchiotti S, Sensi M, Canevari S, Pilotti S.
PMID: 30486883
Cancer Commun (Lond). 2018 Nov 28;38(1):70. doi: 10.1186/s40880-018-0339-3.

BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, and poorly investigated simple sarcoma with a low frequency of genetic deregulation other than an Ewing sarcoma RNA binding protein 1 (EWSR1)-Wilm's tumor suppressor (WT1) translocation. We used...

Cite
Devecchi A, De Cecco L, Dugo M, et al. The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer Commun (Lond). 2018;38(1):70doi: 10.1186/s40880-018-0339-3.
Devecchi, A., De Cecco, L., Dugo, M., Penso, D., Dagrada, G., Brich, S., Stacchiotti, S., Sensi, M., Canevari, S., & Pilotti, S. (2018). The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer communications (London, England), 38(1), 70. https://doi.org/10.1186/s40880-018-0339-3
Devecchi, Andrea, et al. "The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response." Cancer communications (London, England) vol. 38,1 (2018): 70. doi: https://doi.org/10.1186/s40880-018-0339-3
Devecchi A, De Cecco L, Dugo M, Penso D, Dagrada G, Brich S, Stacchiotti S, Sensi M, Canevari S, Pilotti S. The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer Commun (Lond). 2018 Nov 28;38(1):70. doi: 10.1186/s40880-018-0339-3. PMID: 30486883; PMCID: PMC6260689.
Copy Download .nbib Format: NLM
Corrigendum to "Challenges in the clinical interpretation of small de novo copy number variants in neurodevelopmental disorders" [Gene 706 (2019) 162-171].

Gene

Magini P, Scarano E, Donati I, Sensi A, Mazzanti L, Perri A, Tamburrino F, Mongelli P, Percesepe A, Visconti P, Parmeggiani A, Seri M, Graziano C.
PMID: 32037035
Gene. 2020 Apr 20;735:144393. doi: 10.1016/j.gene.2020.144393. Epub 2020 Feb 06.

No abstract available.

Cite
Magini P, Scarano E, Donati I, et al. Corrigendum to "Challenges in the clinical interpretation of small de novo copy number variants in neurodevelopmental disorders" [Gene 706 (2019) 162-171]. Gene. 2020;735:144393doi: 10.1016/j.gene.2020.144393.
Magini, P., Scarano, E., Donati, I., Sensi, A., Mazzanti, L., Perri, A., Tamburrino, F., Mongelli, P., Percesepe, A., Visconti, P., Parmeggiani, A., Seri, M., & Graziano, C. (2020). Corrigendum to "Challenges in the clinical interpretation of small de novo copy number variants in neurodevelopmental disorders" [Gene 706 (2019) 162-171]. Gene, 735144393. https://doi.org/10.1016/j.gene.2020.144393
Magini, Pamela, et al. "Corrigendum to "Challenges in the clinical interpretation of small de novo copy number variants in neurodevelopmental disorders" [Gene 706 (2019) 162-171]." Gene vol. 735 (2020): 144393. doi: https://doi.org/10.1016/j.gene.2020.144393
Magini P, Scarano E, Donati I, Sensi A, Mazzanti L, Perri A, Tamburrino F, Mongelli P, Percesepe A, Visconti P, Parmeggiani A, Seri M, Graziano C. Corrigendum to "Challenges in the clinical interpretation of small de novo copy number variants in neurodevelopmental disorders" [Gene 706 (2019) 162-171]. Gene. 2020 Apr 20;735:144393. doi: 10.1016/j.gene.2020.144393. Epub 2020 Feb 06. PMID: 32037035.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 216 entries